THE University of Manitoba has launched an investigation into a Winnipeg physician involved in a controversial overseas stem-cell clinical trial. It's the fifth such investigation underway related to Regenetek, a Winnipeg-based company that charged roughly 70 multiple sclerosis and ALS patients from all over the world as much as $45,000 for stem-cell treatment at a hospital in India.
http://ift.tt/1E1LMDQ
No comments:
Post a Comment